These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3742032)

  • 1. [Effect of perfluorocarbon emulsions on the protective properties of cardioplegic solutions].
    Ivanitskiĭ GR; Beloiartsev FF; Islamov BI; Onishchenko NA; Lubiako AA
    Biull Eksp Biol Med; 1986 Aug; 102(8):183-5. PubMed ID: 3742032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved myocardial protection with perfluorocarbon cardioplegia.
    Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
    Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.
    Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of perfluorocarbon emulsions in cell culture.
    Ju LK; Armiger WB
    Biotechniques; 1992 Feb; 12(2):258-63. PubMed ID: 1616720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perflubron emulsion increases subcutaneous tissue oxygen tension in rats.
    Rosen NA; Hopf HW; Hunt TK
    Wound Repair Regen; 2006; 14(1):55-60. PubMed ID: 16476072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluorocarbon cardioplegia to protect the myocardium from ischemic damage].
    Islamov BI
    Kardiologiia; 1985 Dec; 25(12):97-100. PubMed ID: 4094318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of cardioplegia using a fluorocarbon emulsion or blood].
    Islamov BI
    Anesteziol Reanimatol; 1986; (4):17-20. PubMed ID: 3777505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-ischemic protection of the myocardium during cardioplegia on the basis of fluorocarbon emulsions].
    Islamov BI
    Grudn Khir; 1986; (5):31-4. PubMed ID: 3781306
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of hydrocortisone on the myocardium during anoxic arrest.
    Appelbaum A; Gotsman MS; Raz S; Ovil Y; Borman JB
    Isr J Med Sci; 1981 Jan; 17(1):8-11. PubMed ID: 7461950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial oxygen tension during surgical revascularization. A clinical comparison between blood cardioplegia and crystalloid cardioplegia.
    Bjerrum JT; Perko MJ; Beck B
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):181-5. PubMed ID: 16387508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of myocardium protection with warm blood cardioplegia].
    Chen RW; Wang ZW; Xu FX
    Zhonghua Wai Ke Za Zhi; 1994 May; 32(5):306-9. PubMed ID: 7842950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenosine triphosphate: an additive myocardial agent in cardioplegia].
    Mochizuki Y; Yata Y; Miyamoto H; Sasaki T; Horikoshi S; Arai T
    Rinsho Kyobu Geka; 1989 Apr; 9(2):176-9. PubMed ID: 9301916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic enhancement of myocardial preservation during cardioplegic arrest.
    Rousou JA; Engelman RM; Anisimowicz L; Lemeshow S; Dobbs WA; Breyer RH; Das DK
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):270-6. PubMed ID: 3945094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myocardial metabolism with microdialysis after protection with cold blood- or cold crystalloid cardioplegia. A porcine model.
    Runge M; Hughes P; Peter Gøtze J; Petersen RH; Steinbrüchel DA
    Scand Cardiovasc J; 2006 Jun; 40(3):186-93. PubMed ID: 16798667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perfusion protection of ischemic liver using perfluorocarbon emulsion].
    Kozlov SA; Novosadov VM; Kiselev EN; Sidliarov DP; Akhsianov UU; Afonin NI
    Biull Eksp Biol Med; 1990 Feb; 109(2):124-5. PubMed ID: 2337639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.